Kyowa Kirin Co., Ltd., a prominent biopharmaceutical company, is headquartered in Tokyo, Japan (JP). Founded in 1949, the company has established a strong presence in the global healthcare industry, focusing on innovative drug development in areas such as oncology, nephrology, and immunology. Kyowa Kirin is renowned for its unique biologics and small molecule therapies, which leverage advanced technologies to address unmet medical needs. The company has achieved significant milestones, including the successful launch of several key products that have positioned it as a leader in the biopharmaceutical sector. With a commitment to research and development, Kyowa Kirin continues to expand its operational footprint across major regions, including North America, Europe, and Asia, solidifying its market position through strategic partnerships and a robust pipeline of therapeutic solutions.
How does Kyowa Kirin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Kyowa Kirin's score of 76 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Kyowa Kirin reported total greenhouse gas emissions of approximately 16,133,000 kg CO2e for Scope 1, 2, and 3 combined, with Scope 1 emissions at 16,133,000 kg CO2e and Scope 2 emissions at 2,087,000 kg CO2e. The company also disclosed significant Scope 3 emissions, including 57,473,000 kg CO2e from capital goods and 98,054,000 kg CO2e from purchased goods and services. Kyowa Kirin has set ambitious reduction targets, aiming for a 55% reduction in Scope 1 and Scope 2 emissions by 2030 compared to 2019 levels. Additionally, the company targets a 30% reduction in Scope 3 emissions by the same year. These targets are part of a broader commitment to achieve net-zero greenhouse gas emissions across its entire value chain by 2050, as outlined in the Kirin Group Environmental Vision 2050. The company’s emissions data is cascaded from its parent organization, Kirin Holdings Company, Limited, which influences its sustainability initiatives. Kyowa Kirin's commitment to reducing its carbon footprint aligns with industry standards and reflects a proactive approach to climate change mitigation.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 17,244,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 34,687,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Kyowa Kirin's Scope 3 emissions, which increased by 5% last year and increased by approximately 37% since 2022, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 60% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Kyowa Kirin has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Common questions about Kyowa Kirin's sustainability data and climate commitments